advertisement
Lee R 43
Showing records 1 to 25 | Display all abstracts from Lee R127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Zhao AT
American Journal of Ophthalmology 2025; 280: 120-129
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Pham K
Ophthalmology 2025; 132: 1212-1216
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Zhu Y
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Pham K
Ophthalmology 2025; 132: 1212-1216
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Di Rosa I
BMJ open ophthalmology 2025; 10:
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Di Rosa I
American Journal of Ophthalmology 2025; 280: 120-129
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Jin F
Ophthalmology 2025; 132: 1212-1216
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Moksha L
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Edziah AA
BMJ open ophthalmology 2025; 10:
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Jin F
Ophthalmology 2025; 132: 1212-1216
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Salowe R
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Salowe R
BMJ open ophthalmology 2025; 10:
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Lee R
Ophthalmology 2025; 132: 1212-1216
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Salowe R
American Journal of Ophthalmology 2025; 280: 120-129
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Chen Y
BMJ open ophthalmology 2025; 10:
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Jin F
American Journal of Ophthalmology 2025; 280: 120-129
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Di Rosa I
Ophthalmology 2025; 132: 1212-1216
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Jin F
American Journal of Ophthalmology 2025; 280: 120-129
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Vrathasha V; Pham K; Pham K
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Lee R
BMJ open ophthalmology 2025; 10:
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Salowe R
Ophthalmology 2025; 132: 1212-1216
127962 Predictors of Glaucoma Conversion in an African Ancestry Cohort: A Longitudinal Study
Lee R; Aibo MI
American Journal of Ophthalmology 2025; 280: 120-129
127484 Sloping retina: a novel feature associated with primary open-angle glaucoma in an African ancestry cohort
Zhu Y
BMJ open ophthalmology 2025; 10:
127256 Integrating neuroprotection, antioxidative effects, and precision medicine in glaucoma management with bioactive compounds
Aibo MI
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2025; 190: 118319
128459 Association between Nucleoside and Nucleotide Reverse Transcriptase Inhibitor Use and Primary Open-Angle Glaucoma Risk in All of Us
Ying GS
Ophthalmology 2025; 132: 1212-1216
